ReviewPharmacogenomics and personalized medicine2021

Clinical Development of AKT Inhibitors and Associated Predictive Biomarkers to Guide Patient Treatment in Cancer Medicine.

Niamh Coleman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.